SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001564590-22-037667
Filing Date
2022-11-14
Accepted
2022-11-14 17:05:41
Documents
68
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q/A acer-10qa_20220630.htm   iXBRL 10-Q/A 2798661
2 EX-31.1 acer-ex311_7.htm EX-31.1 17678
3 EX-31.2 acer-ex312_8.htm EX-31.2 17689
4 EX-32.1 acer-ex321_6.htm EX-32.1 7891
5 EX-32.2 acer-ex322_9.htm EX-32.2 7475
6 GRAPHIC gigazvn340wr000001.jpg GRAPHIC 5627
  Complete submission text file 0001564590-22-037667.txt   10387083

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA acer-20220630.xsd EX-101.SCH 72111
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE acer-20220630_cal.xml EX-101.CAL 44336
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acer-20220630_def.xml EX-101.DEF 279633
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE acer-20220630_lab.xml EX-101.LAB 529093
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acer-20220630_pre.xml EX-101.PRE 447390
62 EXTRACTED XBRL INSTANCE DOCUMENT acer-10qa_20220630_htm.xml XML 1758953
Mailing Address ONE GATEWAY CENTER (300 WASHINGTON ST.) SUITE 356 NEWTON MA 02458
Business Address ONE GATEWAY CENTER (300 WASHINGTON ST.) SUITE 356 NEWTON MA 02458 (844) 902-6100
Acer Therapeutics Inc. (Filer) CIK: 0001069308 (see all company filings)

IRS No.: 320426967 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-33004 | Film No.: 221387394
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences